Scientists, doctors, advocacy workers, and other community members gathered to discuss the next frontier of treating substance-use disorders and addiction: psychedelics. The meeting was convened by the Center for Novel Therapeutics in Addiction Psychiatry led by Nathan Sackett, MD.
Inside the Seattle lecture room where experts are brainstorming the future of psychedelic research
The Seattle Times | April 23, 2022